LJLinglin Jiang

Linglin Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Linglin Jiang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Changchun Cao

    Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China

    1 shared publication
  • Dawei Chen

    Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Jing Li

    Department of Nephrology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China

    1 shared publication
  • Jing Zhao

    Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China

    1 shared publication
  • Mengqing Ma

    Department of Nephrology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China

    1 shared publication
  • Xin Wan

    Department of Nephrology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

    1 shared publication

Latest Publications

  • Open Access

    Interaction of Acute Respiratory Failure and Acute Kidney Injury on in-Hospital Mortality of Patients with Acute Exacerbation COPD

    by Dawei Chen, Linglin Jiang, Jing Li, Yan Tan, Mengqing Ma, Changchun Cao, Jing Zhao, Xin Wan

    Purpose: Both acute respiratory failure (ARF) and acute kidney injury (AKI) are two common complications in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Moreover, both ARF and AKI are reported as increasing the risk of mortality of patients with AECOPD. However, the interaction of ARF and AKI on the mortality of patients with AECOPD remains unknown. Therefore, the aim of this study is to investigate the joint effect of ARF and AKI on in-hospital mortality in AECOPD patients. Patients and Methods: We performed a retrospective, observational cohort study of data from Nanjing First Hospital. The effect of AKI and ARF on in-hospital mortality was assessed using a multivariate logistic regression model. Additive interaction was assessed with the relative excess risk due to interaction. Results: A total of 1647 participants were enrolled. ARF and AKI occurred in 515 (31.3%) and 357 (21.7%) patients, respectively. Overall, in-hospital mortality was 5.7%. The in-hospital mortality of the neither ARF nor AKI group, the ARF only group, the AKI only group, and both the ARF and AKI group were 0.8%, 7.0%, 7.5%, and 29.9%, respectively. After multivariate logistic regression analysis, the independent factors for in-hospital death included: albumin (OR 0.88, 95% CI 0.83– 0.93, P < 0.001), ARF only (OR 8.53, 95% CI 3.64– 19.99, P < 0.001), AKI only (OR 8.99, 95% CI 3.58– 22.55, P < 0.001), and both ARF and AKI (OR 39.13, 95% CI 17.02– 89.97, P < 0.001). The relative excess risk due to interaction was 22.62 (95% CI, 0.31 to 44.93), the attributable proportion due to interaction was 0.59 (95% CI, 0.36 to 0.79), and the synergy index was 2.46 (95% CI, 1.44 to 4.20), indicating ARF and AKI had a significant synergic effect on in-hospital mortality. Conclusion: ARF and AKI had a synergistic effect on in-hospital mortality in AECOPD patients.